| 000 | 00949 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250517113913.0 | ||
| 264 | 0 | _c20170407 | |
| 008 | 201704s 0 0 eng d | ||
| 022 | _a1488-2329 | ||
| 024 | 7 |
_a10.1503/cmaj.1150114 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWilson, R Douglas | |
| 245 | 0 | 0 |
_aA preventable teratology: isotretinoin. _h[electronic resource] |
| 260 |
_bCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne _c09 2016 |
||
| 300 |
_a901 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAbnormalities, Drug-Induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIsotretinoin |
| 650 | 0 | 4 | _aTeratogens |
| 650 | 0 | 4 | _aTeratology |
| 773 | 0 |
_tCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne _gvol. 188 _gno. 12 _gp. 901 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1503/cmaj.1150114 _zAvailable from publisher's website |
| 999 |
_c26395704 _d26395704 |
||